← Back to Search

Communication & Screening Intervention for Lung Cancer

N/A
Recruiting
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
50-80 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights

Study Summary

This trial tests whether a multi-level intervention can improve communication, intentions, and knowledge between providers and patients, as well as referrals for screenings and completion of those screenings.

Who is the study for?
This trial is for English-speaking individuals aged 50-80 who currently smoke or quit within the last 15 years, have a history of heavy smoking (20+ pack-years), and haven't had lung screening in over 13 months. They must be scheduled for an upcoming clinic appointment and able to consent and complete interviews. Those with a history of lung cancer cannot participate.Check my eligibility
What is being tested?
The study is examining the effectiveness of two strategies: 'Provider Prompt' which reminds healthcare providers to discuss lung cancer screening, and 'Patient Outreach & Education' aimed at increasing patient knowledge about screening benefits.See study design
What are the potential side effects?
Since this trial focuses on communication strategies rather than medical treatments, there are no direct side effects from medications involved. However, participants may experience anxiety or stress related to discussions about lung cancer screenings.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
lung cancer screening intentions
lung cancer screening knowledge
provider-patient discussion
Secondary outcome measures
lung cancer screening completion rates
lung cancer screening referrals

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Multilevel InterventionExperimental Treatment1 Intervention
Group II: Nonequivalent Control GroupActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor
343 Previous Clinical Trials
136,134 Total Patients Enrolled

Media Library

Provider Prompt & Patient Outreach and Education Clinical Trial Eligibility Overview. Trial Name: NCT04675476 — N/A
Lung Cancer Research Study Groups: Multilevel Intervention, Nonequivalent Control Group
Lung Cancer Clinical Trial 2023: Provider Prompt & Patient Outreach and Education Highlights & Side Effects. Trial Name: NCT04675476 — N/A
Provider Prompt & Patient Outreach and Education 2023 Treatment Timeline for Medical Study. Trial Name: NCT04675476 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this trial open at the present time?

"This research trial, which was initially hosted on December 1st 2022 and last edited on March 24th 2022 is not currently accepting applications. Nevertheless, there are 1635 other studies actively recruiting participants at this present time."

Answered by AI

Is self-enrollment feasible for this investigation?

"Patients with lung cancer between the ages of 55 and 80 may qualify for this study, which is seeking to enroll around 368 participants."

Answered by AI

Does this experiment accommodate participants who are over 55 years of age?

"Elderly people aged 55 to 80 years old can be enlisted in this medical trial."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
2024. "A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04675476.
~245 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top